Literature DB >> 6779318

Reduction of barbiturate anaesthesia by new glutarimide compounds in mice.

V K Patel, M N Jindal, N B Patel, H Venkatakrishna-Bhatt.   

Abstract

Newly synthesized glutarimide compounds (Table 1) at doses of 4, 8 and 16 mg/kg (IP) reduced the duration of sleep induced by pentobarbitone in mice. Compounds 1 to 7 and 21 were more potent than the other compounds and their activity was comparable to the reference drug, bemegride. The structure activity relationship for the decrease in duration of barbiturate anaesthesia caused by the various groups of these compounds was mainly found to be inversely related to the length of the alkyl side chain at position 4 of the beta carbon atom. It was also shown that the presence of piperidine, diethylamine and morpholine moieties attached to 3,5-dicyanoglutarimide was partly responsible for the reduction in barbiturate anaesthesia by these compounds.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6779318     DOI: 10.1007/bf00433262

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  4 in total

1.  The pharmacology of central and peripheral inhibition.

Authors:  D R CURTIS
Journal:  Pharmacol Rev       Date:  1963-06       Impact factor: 25.468

2.  Analeptics.

Authors:  F HAHN
Journal:  Pharmacol Rev       Date:  1960-12       Impact factor: 25.468

3.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

4.  Central nervous system effects of thalidomide.

Authors:  W L KUHN; E F VAN MAANEN
Journal:  J Pharmacol Exp Ther       Date:  1961-10       Impact factor: 4.030

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.